These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33843854)

  • 1. Highlights from the XVIII International Workshop on Chronic Lymphocytic Leukemia: commentary.
    O'Brien SM
    Clin Adv Hematol Oncol; 2019 Nov; 17 Suppl 16(11):24-27. PubMed ID: 33843854
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights from the XVIII International Workshop on Chronic Lymphocytic Leukemia.
    Clin Adv Hematol Oncol; 2019 Nov; 17 Suppl 16(11):1-28. PubMed ID: 33843853
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progress of chronic lymphocytic leukemia: conference report from the XVI international workshop on chronic lymphocytic leukemia (iwCLL)].
    Wu J; Xu W; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):174-6. PubMed ID: 27014993
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. International Workshop on Chronic Lymphocytic Leukemia.
    Ann Intern Med; 1989 Feb; 110(3):236-8. PubMed ID: 2912362
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in chronic lymphocytic leukemia from the 60th American Society of Hematology Annual Meeting: commentary.
    O'Brien SM
    Clin Adv Hematol Oncol; 2019 Jan; 17 Suppl 1(1):20-23. PubMed ID: 31545308
    [No Abstract]   [Full Text] [Related]  

  • 6. IVth International Workshop on Chronic Lymphocytic Leukemia. Paris, September 4-7, 1988. Proceedings.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):261-481. PubMed ID: 3222142
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights in chronic lymphocytic leukemia from the 2017 American Society of Hematology Annual Meeting: commentary.
    O'Brien SM
    Clin Adv Hematol Oncol; 2018 Jan; 16 Suppl 2(1):16-19. PubMed ID: 29742092
    [No Abstract]   [Full Text] [Related]  

  • 8. 7th International Workshop on Chronic Lymphocytic Leukemia. Crete, Greece, May 2-4, 1997. Proceedings and abstracts.
    Hematol Cell Ther; 1997 Nov; 39 Suppl 1():S1-103. PubMed ID: 9537789
    [No Abstract]   [Full Text] [Related]  

  • 9. Additional abstracts from the XII International Workshop on Chronic Lymphocytic Leukemia. September 14-16, 2007. London, United Kingdom.
    Leuk Lymphoma; 2007 Nov; 48(11):2267-74. PubMed ID: 18398965
    [No Abstract]   [Full Text] [Related]  

  • 10. Abstracts from the XII International Workshop on CLL (chronic lymphocytic leukemia), 14-16 September 2007, London, United Kingdom.
    Leuk Lymphoma; 2007 Sep; 48 Suppl 1():S3-186. PubMed ID: 17763090
    [No Abstract]   [Full Text] [Related]  

  • 11. Current issues in chronic lymphocytic leukemia.
    Gale RP
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):263-5. PubMed ID: 3065726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia.
    Hallek M; Kay NE; Osterborg A; Chanan-Khan AA; Mahler M; Salman M; Wan Y; Sun S; Zhuang SH; Howes A
    Future Oncol; 2015; 11(1):51-9. PubMed ID: 24901734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VIII International Workshop on Chronic Lymphocytic Leukaemia. 29-31 October 1999, Paris, France. Proceedings and abstracts.
    Hematol Cell Ther; 2000 Jun; 42(1):1-116. PubMed ID: 11036943
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia.
    Gale RP; Caligaris-Cappio F; Dighiero G; Keating M; Montserrat E; Rai K
    Leukemia; 1994 Sep; 8(9):1610-4. PubMed ID: 7522296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights From the XVII International Workshop on Chronic Lymphocytic Leukemia: Commentary.
    O'Brien SM
    Clin Adv Hematol Oncol; 2017 Jul; 15 Suppl 6(7):13-15. PubMed ID: 28837123
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
    J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOHO State of the Art Updates and Next Questions: The Conundrum in Assessing the Therapy Response of Patients With Chronic Lymphocytic Leukemia.
    Choi MY; Wang HY; Kipps TJ
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):321-325. PubMed ID: 31204237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate.
    Castelli R; Vismara A; Pavia G; Dagani R; Porro T
    Ann Ital Med Int; 2002; 17(1):47-50. PubMed ID: 11975114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Workshop on chronic lymphocytic leukemia and hairy cell leukemia. Results of a consensus conference of the German CLL Cooperative Group. Peer-reviewed proceedings. Berlin, Germany, February 7-10, 1996.
    Leukemia; 1997 Apr; 11 Suppl 2():S1-64. PubMed ID: 9213634
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of chronic leukemic lymphocytic leukemia, chronic subleukemic lymphocytic leukemia, and lymphocytic sarcoma.
    BIGLEY RH; KOLER RD; PIROFSKY B; OSGOOD EE
    Cancer Chemother Rep; 1962 Feb; 16():231-4. PubMed ID: 13869131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.